Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer
- Conditions
- Head and Neck Cancer
- Registration Number
- NCT00963326
- Lead Sponsor
- Centre Oscar Lambret
- Brief Summary
RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at blood and tissue samples from patients with larynx cancer, pharynx cancer, or oral cavity cancer.
- Detailed Description
OBJECTIVES:
Primary
* Characterize, morphologically and molecularly, squamous cell carcinoma of the larynx, pharynx, or oral cavity in patients without high-risk factors, such as alcohol consumption, smoking, or occupation.
Secondary
* Study the impact parameters of morphology, molecular characteristics, and genomics on disease-free survival and overall survival of these patients.
* Study the impact parameters of morphological, molecular, and genomic control in the tumor.
* Assess, in advanced tumors, the risk of heterogeneity of morphological, molecular, and genomic control in the tumor.
OUTLINE: This is a multicenter study.
Blood, tumor tissue, and healthy tissue samples are collected before treatment begins.
Patients are followed up every 3 months for 2 years (additional biopsies may be collected).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor response rate by RECIST criteria
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centre Oscar Lambret
🇫🇷Lille, France